Once-daily oral therapy for feline diabetes mellitus: SGLT-2-inhibitor velagliflozin as standalone therapy compared to insulin injection therapy in diabetic cats. Research Communications of the 32nd ECVIM-CA Congress, 2022: Göteborg (Schweden), 1. – 3. September - Niessen, S JM; Voth, R; Kroh, C; Hennings, L